Tag: OPM
Correction: OPM: 10 million cash, visibility until early 2025
(AOF) – An error crept into the title of our dispatch this morning on OPM. The net loss figure has been corrected. Oncodesign precision medicine (OPM) announces cash flow of…
Correction: OPM: 10 million in cash, visibility until early 2025 – 03/27/2024 at 11:18
(AOF) – An error crept into the title of our dispatch this morning on OPM. The net loss figure has been corrected. Oncodesign precision medicine (OPM) announces cash flow of…
OPM announces its 2023 annual results and provides an update on its clinical developments – 03/26/2024 at 6:00 p.m.
To receive information from ONCODESIGN PRECISION MEDICINE (OPM) in real time, send a request to [email protected] Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Ticker: ALOPM), a biopharmaceutical company specializing in precision…
OPM confident in its prospects 1 year and a half after its split – 05/12/2023 at 6:20 p.m.
(AOF) – “The OPM project generates very great confidence”. This is the message that Oncodesign Precision Medicine, a company resulting in 2022 from the split from Oncodesign, wanted to convey…
OPM confident in its prospects 1 year and a half after its split
(AOF) – “The OPM project generates very great confidence”. This is the message that Oncodesign Precision Medicine, a company resulting in 2022 from the split from Oncodesign, wanted to convey…
OPM announces positive interim results from its phase 1 study evaluating OPM-101 in healthy volunteers
By Hector Chaunu Published on 02/10/2023 at 6:48 p.m. (Boursier.com) — Oncodesign Precision Medicine, a biopharmaceutical company specializing…
Minutes of the OPM Combined General Meeting of May 30, 2023 – 05/30/2023 at 6:00 p.m.
To receive information from ONCODESIGN PRECISION MEDICINE (OPM) in real time, send a request to [email protected] Appointment of Florence Dupré as administrator of the Board of Directors Oncodesign Precision Medicine…
Oncodesign: delivery of OPM shares on Friday, October 7
By Alexandra Saintpierre Published on 03/10/2022 at 07:49 (Boursier.com) — The…
Oncodesign’s General Meeting authorizes the allocation of Oncodesign Precision Medicine (OPM) shares to Oncodesign shareholders – 09/30/2022 at 6:00 p.m.
Dijon (France), September 30, 2022 at 6:00 p.m. – The Oncodesign General Meeting held on September 30, 2022 authorized the distribution of OPM shares to Oncodesign shareholders. Each Oncodesign shareholder…
Euronext Paris authorizes the listing of Oncodesign Precision Medicine (OPM) shares on Euronext Access+ as part of the allocation of OPM shares to Oncodesign shareholders – 09/28/2022 at 6:00 p.m.
– IPO planned at a reference price of €0.817/share – Fundraising in the amount of €8 million, guaranteed by OPM management, planned before the end of 2022 – Availability of…
Oncodesign: Servier lifts the exclusive worldwide license option on the program in collaboration with OPM
By Alexandra Saintpierre Published on 09/26/2022 at 7:14 p.m. Photo credit © Reuters …